PAM
AXSM icon

Panagora Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Panagora Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,231
Closed -$2.45M – 1140
2024
Q3 		$2.45M Buy
+27,231
New +$2.38M 0.01% 499
2022
Q3 		– Sell
-20,415
Closed -$782K – 1439
2022
Q2 		$782K Buy
20,415
+7,695
+60% +$243K 0.01% 988
2022
Q1 		$526K Buy
+12,720
New +$394K ﹤0.01% 1189
2020
Q4 		– Sell
-7,291
Closed -$519K – 2807
2020
Q3 		$519K Sell
7,291
-3,555
-33% -$277K ﹤0.01% 1152
2020
Q2 		$892K Buy
+10,846
New +$835K 0.01% 973

Other funds holding AXSM

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Panagora Asset Management's AXSM Position: Q4 2024 in Review

Panagora Asset Management sold out of Axsome Therapeutics (AXSM) in Q4 2024, closing a stake of 27,231 shares — an estimated $2.45M sold.

Panagora Asset Management first reported a position in AXSM in Q2 2020 and held it in 5 quarters. The position peaked at $2.45M in Q3 2024. 292 funds tracked by Wall St. Rank hold AXSM as of Q4 2024.

  • Panagora Asset Management reported no remaining Axsome Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Panagora Asset Management sold 27,231 Axsome Therapeutics shares in Q4 2024, an estimated $2.45M.
  • Panagora Asset Management first reported a position in Axsome Therapeutics in Q2 2020 and held it in 5 quarters.
  • Panagora Asset Management's Axsome Therapeutics position peaked at $2.45M in Q3 2024.
  • 292 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2024.

Based on Panagora Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.